Danaher Corp. Stock (ISIN: US2358511028) Slides Amid Masimo Acquisition Scrutiny and Conservative Guidance

robot
Abstract generation in progress

Danaher Corp. (NYSE: DHR) stock experienced a sharp decline following investor concerns over its $9.9 billion acquisition of Masimo Corp. and conservative 2026 guidance. The deal has significantly increased Danaher’s debt-to-equity ratio, raising leverage worries, despite the company’s strong Q4 2025 results. Analysts maintain a “Moderate Buy” rating, focusing on long-term value from the diagnostics segment and the company’s robust consumables business, while cautioning investors about potential integration risks and market volatility.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin